GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHF) » Definitions » Net Change in Cash

SNPHF (Santen Pharmaceutical Co) Net Change in Cash : $136 Mil (TTM As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Santen Pharmaceutical Co's Net Change in Cash for the three months ended in Sep. 2024 was $-37 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was $136 Mil.


Santen Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Santen Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Net Change in Cash Chart

Santen Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 191.64 -262.58 169.72 -187.87 244.82

Santen Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.98 120.18 83.78 -30.65 -37.08

Santen Pharmaceutical Co Net Change in Cash Calculation

Santen Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Mar. 2024 is calculated as

Santen Pharmaceutical Co's Net Change in Cash for the quarter that ended in Sep. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $136 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Santen Pharmaceutical Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co Headlines